ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/04/05 | 日証協 | 264,910株 | -10.61% | 51,637株 | -76.99% | 189,738株 | +1.66% | 22,897株 | -24.16% |
2024/03/29 | 日証協 | 296,357株 | -2.72% | 224,381株 | +15.69% | 186,634株 | -10.74% | 30,193株 | +284.13% |
2024/03/22 | 日証協 | 304,655株 | -2.05% | 193,948株 | +3.82% | 209,102株 | -8.98% | 7,860株 | -50.39% |
2024/03/15 | 日証協 | 311,035株 | -2.59% | 186,804株 | +12.34% | 229,743株 | -4.17% | 15,845株 | -53.56% |
2024/03/08 | 日証協 | 319,301株 | +8.29% | 166,291株 | +3364.4% | 239,743株 | +8.52% | 34,120株 | -26.05% |
2024/03/01 | 日証協 | 294,855株 | +0.49% | 4,800株 | -78.92% | 220,914株 | +11.51% | 46,140株 | +86.35% |
2024/02/22 | 日証協 | 293,415株 | +9.6% | 22,772株 | -68.43% | 198,104株 | +10.36% | 24,760株 | -26.32% |
2024/02/16 | 日証協 | 267,715株 | +13.43% | 72,137株 | +18.74% | 179,513株 | +15.21% | 33,607株 | +7.77% |
2024/02/09 | 日証協 | 236,015株 | +3.95% | 60,750株 | -20.24% | 155,813株 | +5.13% | 31,184株 | -13.53% |
2024/02/02 | 日証協 | 227,056株 | -1.51% | 76,165株 | -41.76% | 148,205株 | -30.15% | 36,063株 | -41.31% |
2024/01/26 | 日証協 | 230,527株 | +70.65% | 130,781株 | +2343.13% | 212,180株 | +14.77% | 61,443株 | +506.9% |
2024/01/19 | 日証協 | 135,085株 | +1.54% | 5,353株 | -93.72% | 184,875株 | +1.52% | 10,124株 | -78.85% |
2024/01/12 | 日証協 | 133,035株 | +37.23% | 85,295株 | +934.25% | 182,111株 | -1.63% | 47,869株 | +220.69% |
2024/01/05 | 日証協 | 96,945株 | -1.85% | 8,247株 | -62.51% | 185,132株 | +0.7% | 14,927株 | +29.47% |
2023/12/29 | 日証協 | 98,768株 | +22.53% | 21,998株 | -48.65% | 183,844株 | -2.63% | 11,529株 | -55.06% |
2023/12/22 | 日証協 | 80,606株 | +44.18% | 42,841株 | +124.44% | 188,810株 | -17.52% | 25,655株 | +6.34% |
2023/12/15 | 日証協 | 55,906株 | -4.76% | 19,088株 | +28.21% | 228,916株 | -1.47% | 24,126株 | -74.94% |
2023/12/08 | 日証協 | 58,703株 | +4.08% | 14,888株 | -83.33% | 232,331株 | -1% | 96,272株 | -73.51% |
2023/12/01 | 日証協 | 56,403株 | +12.91% | 89,323株 | +77.99% | 234,688株 | +71.53% | 363,438株 | +1503.24% |
※株式分割は考慮していませんのでご注意ください。
Page Top